| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter binding | 4.78e-06 | 172 | 185 | 10 | GO:0044325 | |
| GeneOntologyMolecularFunction | protein kinase activity | ANKK1 STK36 PDK1 NTRK2 CDK10 JAK1 STK10 PIK3C3 MAP4K5 TBK1 ROCK1 ATM STK40 MAPK8 LYN POMK EPHA8 | 4.53e-05 | 600 | 185 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 8.95e-05 | 10 | 185 | 3 | GO:0140031 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA13 SMC1A RNF213 CHD9 ATP13A5 CHD4 HELQ MDN1 ACIN1 CHD6 CARNS1 DYNC1H1 VCP | 2.49e-04 | 441 | 185 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 2.55e-04 | 3 | 185 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ANKK1 STK36 PDK1 NTRK2 CDK10 JAK1 STK10 PIK3C3 MAP4K5 TBK1 ROCK1 ATM STK40 MAPK8 LYN POMK EPHA8 | 3.33e-04 | 709 | 185 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.71e-04 | 37 | 185 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | mediator complex binding | 5.06e-04 | 4 | 185 | 2 | GO:0036033 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | STK36 ANK3 STAG1 SMC1A CNTRL NUMA1 CDC20B MEI1 HAUS2 DST AKAP9 ARHGEF10 TTC12 CFAP206 ROCK1 CFAP74 MAPK8 DYNC1H1 VCP DEUP1 | 7.21e-06 | 720 | 184 | 20 | GO:0000226 |
| GeneOntologyBiologicalProcess | organelle assembly | KNTC1 STK36 NRAP TBC1D30 STAG1 SYNE1 SMC1A CNTRL NUMA1 CDC20B RNF213 HAUS2 CDK10 USP10 MDN1 ARHGEF10 PIK3C3 TTC12 PACS2 CFAP206 CFAP74 ATM TRAPPC14 MAPK8 DYNC1H1 DEUP1 | 9.82e-06 | 1138 | 184 | 26 | GO:0070925 |
| GeneOntologyBiologicalProcess | establishment of mitotic sister chromatid cohesion | 2.38e-05 | 7 | 184 | 3 | GO:0034087 | |
| GeneOntologyCellularComponent | microtubule organizing center | CEP104 RAPGEF6 GPAA1 TBC1D30 CNTRL NUMA1 EVC CHD4 HAUS2 CDK10 AKAP9 ARHGEF10 CROCC2 TTC12 LRP1 NLRC5 CFAP206 ROCK1 ATM TRAPPC14 DYNC1H1 DEUP1 | 2.23e-05 | 919 | 185 | 22 | GO:0005815 |
| HumanPheno | Disinhibition | CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292 | 1.93e-05 | 807 | 72 | 26 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292 | 1.93e-05 | 807 | 72 | 26 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292 | 1.93e-05 | 807 | 72 | 26 | HP:5200123 |
| HumanPheno | Social disinhibition | CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292 | 1.93e-05 | 807 | 72 | 26 | HP:5200029 |
| HumanPheno | Perseverative thought | ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 TBK1 PACS2 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP | 5.17e-05 | 377 | 72 | 16 | HP:0030223 |
| HumanPheno | Abnormal social development | CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 ITPR1 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292 | 5.44e-05 | 908 | 72 | 27 | HP:0025732 |
| HumanPheno | Disordered formal thought process | ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 TBK1 PACS2 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP | 6.89e-05 | 386 | 72 | 16 | HP:0025769 |
| HumanPheno | Abnormally increased volition | CEP104 PSAT1 ANK3 NRCAM NTRK2 SMC1A ZSWIM6 HUWE1 SHOC2 CDK10 PACS1 TRANK1 ANAPC1 ASL TBK1 PACS2 FTL ATM TRAPPC14 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP ZNF292 | 7.24e-05 | 869 | 72 | 26 | HP:5200263 |
| HumanPheno | Abnormal thought pattern | ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 TBK1 PACS2 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP | 1.19e-04 | 404 | 72 | 16 | HP:5200269 |
| HumanPheno | Motor stereotypy | ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 PACS2 KCNT1 TRAPPC9 PUS7 VCP | 1.20e-04 | 280 | 72 | 13 | HP:0000733 |
| HumanPheno | Restricted or repetitive behaviors or interests | ANK3 NTRK2 SMC1A KAT6A ZSWIM6 HUWE1 ITPR1 TRANK1 PACS2 NIPBL KCNT1 MED12 TRAPPC9 PUS7 VCP | 1.47e-04 | 368 | 72 | 15 | HP:0031432 |
| Domain | ARM-type_fold | CEP104 STK36 STAG1 VEPH1 RICTOR HUWE1 MEI1 CWC22 ITPR1 ITPR2 ARFGEF3 THADA PIK3C3 TTC12 ATM NIPBL EIF3M GPRASP2 | 8.02e-09 | 339 | 185 | 18 | IPR016024 |
| Domain | Kinase-like_dom | ANKK1 STK36 NTRK2 CHD9 CDK10 JAK1 STK10 DST PIK3C3 MAP4K5 TBK1 ROCK1 ATM STK40 MAPK8 LYN POMK EPHA8 | 7.77e-06 | 542 | 185 | 18 | IPR011009 |
| Domain | TPR | 4.38e-05 | 129 | 185 | 8 | SM00028 | |
| Domain | TPR_repeat | 5.44e-05 | 133 | 185 | 8 | IPR019734 | |
| Domain | SAM_1 | 5.73e-05 | 68 | 185 | 6 | PF00536 | |
| Domain | ZU5 | 7.69e-05 | 9 | 185 | 3 | SM00218 | |
| Domain | Phosphofurin_acidic_CS-1 | 9.76e-05 | 2 | 185 | 2 | IPR019381 | |
| Domain | Pacs-1 | 9.76e-05 | 2 | 185 | 2 | PF10254 | |
| Domain | ZU5 | 1.09e-04 | 10 | 185 | 3 | PS51145 | |
| Domain | Ank_3 | 1.09e-04 | 10 | 185 | 3 | PF13606 | |
| Domain | ZU5 | 1.97e-04 | 12 | 185 | 3 | PF00791 | |
| Domain | ZU5_dom | 1.97e-04 | 12 | 185 | 3 | IPR000906 | |
| Domain | - | 2.27e-04 | 207 | 185 | 9 | 1.25.40.10 | |
| Domain | SAM | 2.41e-04 | 88 | 185 | 6 | SM00454 | |
| Domain | SNF2_N | 2.70e-04 | 32 | 185 | 4 | IPR000330 | |
| Domain | SNF2_N | 2.70e-04 | 32 | 185 | 4 | PF00176 | |
| Domain | InsP3_rcpt-bd | 2.91e-04 | 3 | 185 | 2 | IPR000493 | |
| Domain | LRR_1 | 3.44e-04 | 219 | 185 | 9 | PF00560 | |
| Domain | SAM_DOMAIN | 3.65e-04 | 95 | 185 | 6 | PS50105 | |
| Domain | ARM-like | CEP104 STK36 STAG1 RICTOR HUWE1 MEI1 TTC12 NIPBL MED12 GPRASP2 | 3.72e-04 | 270 | 185 | 10 | IPR011989 |
| Domain | Prot_kinase_dom | ANKK1 STK36 NTRK2 CDK10 JAK1 STK10 MAP4K5 TBK1 ROCK1 STK40 MAPK8 LYN POMK EPHA8 | 3.80e-04 | 489 | 185 | 14 | IPR000719 |
| Domain | Leu-rich_rpt | NTRK2 CNTRL SHOC2 RSU1 LRRC31 PRELP NLRC5 LGR6 SLITRK6 NLRP8 | 3.83e-04 | 271 | 185 | 10 | IPR001611 |
| Domain | SAM | 4.08e-04 | 97 | 185 | 6 | IPR001660 | |
| Domain | PROTEIN_KINASE_DOM | ANKK1 STK36 NTRK2 CDK10 JAK1 STK10 MAP4K5 TBK1 ROCK1 STK40 MAPK8 LYN POMK EPHA8 | 4.13e-04 | 493 | 185 | 14 | PS50011 |
| Domain | TPR-like_helical_dom | 5.39e-04 | 233 | 185 | 9 | IPR011990 | |
| Domain | BK_channel_a | 5.78e-04 | 4 | 185 | 2 | PF03493 | |
| Domain | K_chnl_Ca-activ_BK_asu | 5.78e-04 | 4 | 185 | 2 | IPR003929 | |
| Domain | - | 6.55e-04 | 106 | 185 | 6 | 1.10.150.50 | |
| Domain | PROTEIN_KINASE_ATP | ANKK1 STK36 NTRK2 CDK10 JAK1 STK10 MAP4K5 TBK1 ROCK1 STK40 MAPK8 LYN EPHA8 | 6.79e-04 | 459 | 185 | 13 | PS00107 |
| Domain | TPR-contain_dom | 7.47e-04 | 150 | 185 | 7 | IPR013026 | |
| Domain | SAM/pointed | 1.10e-03 | 117 | 185 | 6 | IPR013761 | |
| Domain | TPR_REGION | 1.30e-03 | 165 | 185 | 7 | PS50293 | |
| Domain | TPR | 1.30e-03 | 165 | 185 | 7 | PS50005 | |
| Domain | - | NTRK2 CNTRL SHOC2 RSU1 LRRC31 PRELP NLRC5 LGR6 SLITRK6 NLRP8 | 1.40e-03 | 321 | 185 | 10 | 3.80.10.10 |
| Domain | BRK | 1.43e-03 | 6 | 185 | 2 | SM00592 | |
| Domain | RIH_assoc-dom | 1.43e-03 | 6 | 185 | 2 | IPR013662 | |
| Domain | BRK_domain | 1.43e-03 | 6 | 185 | 2 | IPR006576 | |
| Domain | Ins145_P3_rec | 1.43e-03 | 6 | 185 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.43e-03 | 6 | 185 | 2 | PF08454 | |
| Domain | RIH_dom | 1.43e-03 | 6 | 185 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.43e-03 | 6 | 185 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.43e-03 | 6 | 185 | 2 | IPR015925 | |
| Domain | - | 1.43e-03 | 6 | 185 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.43e-03 | 6 | 185 | 2 | PF01365 | |
| Domain | Liprin | 1.43e-03 | 6 | 185 | 2 | IPR029515 | |
| Domain | BRK | 1.43e-03 | 6 | 185 | 2 | PF07533 | |
| Domain | L_dom-like | NTRK2 CNTRL SHOC2 RSU1 LRRC31 PRELP NLRC5 LGR6 SLITRK6 NLRP8 | 1.64e-03 | 328 | 185 | 10 | IPR032675 |
| Domain | Chromo_domain | 1.66e-03 | 24 | 185 | 3 | IPR023780 | |
| Domain | Pkinase_Tyr | 1.81e-03 | 129 | 185 | 6 | PF07714 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_LOADING | 7.07e-05 | 9 | 136 | 3 | M47868 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 7.07e-05 | 9 | 136 | 3 | M47852 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 1.00e-04 | 10 | 136 | 3 | M27178 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 1.00e-04 | 10 | 136 | 3 | MM14892 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.49e-04 | 202 | 136 | 9 | MM15362 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | RANBP2 NTRK2 POLR2B CNTRL RNF213 RICTOR PSMD11 SHOC2 AKAP9 MAPK8 LYN MAML3 GOLGA4 VCP | 1.56e-04 | 464 | 136 | 14 | M27547 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.60e-04 | 204 | 136 | 9 | M4217 | |
| Pathway | REACTOME_EICOSANOIDS | 1.81e-04 | 12 | 136 | 3 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 1.81e-04 | 12 | 136 | 3 | MM14845 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.13e-04 | 31 | 136 | 4 | M877 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 2.34e-04 | 13 | 136 | 3 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 2.34e-04 | 13 | 136 | 3 | M27661 | |
| Pubmed | RGPD2 RANBP2 ANK2 ANK3 NRCAM SYNE1 NTRK2 PPFIA1 NUMA1 ADGRB3 ARHGEF12 CHD4 HUWE1 PPFIA3 USP10 DST MDN1 AKAP9 ANAPC1 TBK1 CNKSR3 LRP1 MIOS ROCK1 QSER1 PCDH8 NIPBL KCNT1 DYNC1H1 GOLGA4 | 8.82e-15 | 963 | 187 | 30 | 28671696 | |
| Pubmed | RANBP2 PSAT1 ANK3 COPA PPFIA1 POLR2B RNF213 RICTOR PSMD11 HUWE1 BCAR1 PPFIA3 SHOC2 ITPR1 ITPR2 PACS1 TRIM11 MED4 AKAP9 TSR1 CASKIN2 MIOS PDP2 ROCK1 HSD17B3 MAPK8 GOLGA4 | 1.79e-11 | 1049 | 187 | 27 | 27880917 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PSAT1 ANK3 ABHD2 KAT6A EVC RNF213 CHD9 SRSF11 ZSWIM6 HUWE1 BCAR1 RSU1 C2CD2 PKNOX2 ARFGEF3 STK10 PACS1 USP10 THADA PIK3C3 TBK1 XPNPEP3 TTC12 LRP1 NLRC5 CHD6 QSER1 MAML3 EIF3M TRAPPC9 GOLGA4 SOS2 | 2.17e-11 | 1489 | 187 | 32 | 28611215 |
| Pubmed | RANBP2 COPA SMC1A POLR2B NUMA1 RNF213 CHD9 CHD4 PPWD1 USP10 LIG3 TRIM11 MED4 MDN1 TSR1 ANAPC1 HLTF ACIN1 ATM QSER1 NIPBL EIF3M MED12 PUS7 VCP ZNF687 | 4.77e-11 | 1014 | 187 | 26 | 32416067 | |
| Pubmed | ANK2 ANK3 NRCAM COPA STAG1 ENPP2 SYNE1 SMC1A ADGRB3 CHD9 CHD4 HUWE1 NR1D1 JAK1 MED4 MAN1A2 DST ARHGEF10 DROSHA MTIF2 LRP1 CHD6 ATM NIPBL GPRASP2 DYNC1H1 VCP ZNF292 SOS2 | 6.79e-11 | 1285 | 187 | 29 | 35914814 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 RANBP2 RAPGEF6 COPA SMC1A NUMA1 RICTOR CHD4 HUWE1 NR1D1 STK10 PACS1 USP10 MDN1 ANAPC1 ACIN1 PACS2 ATM MAPK8 NIPBL GOLGA4 ZNF687 | 2.46e-10 | 774 | 187 | 22 | 15302935 |
| Pubmed | KNTC1 RANBP2 PSAT1 COPA POLR2B NUMA1 RNF213 SRSF11 CHD4 PSMD11 HUWE1 ITPR1 ITPR2 ARFGEF3 USP10 LIG3 THADA DST MDN1 DIMT1 HLTF ATM TRAPPC14 EIF3M TRAPPC9 DYNC1H1 RBM34 VCP PTCD3 | 9.46e-10 | 1440 | 187 | 29 | 30833792 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 COPA PDK1 SYNE1 SMC1A POLR2B CHD9 SRSF11 CHD4 CWC22 LIG3 DST TSR1 DROSHA XPNPEP3 MIOS ACIN1 CHD6 ATM NIPBL MED12 DYNC1H1 VCP ZNF292 PTCD3 | 9.93e-10 | 1082 | 187 | 25 | 38697112 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANBP2 COPA STAG1 SMC1A PPFIA1 SRSF11 CHD4 PSMD11 HUWE1 SHOC2 USP10 MDN1 ANAPC1 HLTF ACIN1 ATM NIPBL DYNC1H1 | 3.14e-09 | 582 | 187 | 18 | 20467437 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 RANBP2 PSAT1 COPA SYNE1 SMC1A POLR2B NUMA1 CHD4 PSMD11 HUWE1 CWC22 USP10 LIG3 THADA MDN1 DIMT1 TSR1 ANAPC1 TBK1 ACIN1 ATM NIPBL EIF3M DYNC1H1 GOLGA4 RBM34 PTCD3 | 3.27e-09 | 1425 | 187 | 28 | 30948266 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 RGPD2 RANBP2 PHF20 COPA STAG1 CNOT10 SYNE1 SMC1A NUMA1 SHOC2 HAUS2 CWC22 ITPR1 PACS1 ZNHIT6 TSR1 ANAPC1 NDUFAF7 ATM NIPBL EIF3M DYNC1H1 VCP PTCD3 | 3.70e-09 | 1155 | 187 | 25 | 20360068 |
| Pubmed | ANK1 COPA KAT6A NUMA1 CHD4 HUWE1 BCAR1 LARS2 JAK1 DST ARHGEF10 DYNC1H1 VCP | 3.50e-08 | 332 | 187 | 13 | 37433992 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RANBP2 COPA SMC1A NUMA1 RNF213 CHD4 HUWE1 MDN1 TSR1 ANAPC1 ACIN1 NIPBL DYNC1H1 | 3.50e-08 | 332 | 187 | 13 | 32786267 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RANBP2 ANK1 COPA SMC1A POLR2B NUMA1 SRSF11 CHD4 HUWE1 CWC22 ANKRD27 MDN1 DIMT1 TSR1 HLTF ACIN1 CRYBG1 CHD6 LYN NIPBL EIF3M DYNC1H1 RBM34 ZNF687 PTCD3 | 4.90e-08 | 1318 | 187 | 25 | 30463901 |
| Pubmed | RGPD2 RANBP2 RAPGEF6 PPFIA1 CHD4 HUWE1 DST ANAPC1 TBK1 LRP1 CHD6 MED12 GPRASP2 ZNF687 | 7.16e-08 | 418 | 187 | 14 | 34709266 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 COPA SMC1A POLR2B NUMA1 RICTOR CHD4 PSMD11 HUWE1 ANKRD27 LIG3 DST MDN1 DIMT1 MAP4K5 HLTF ACIN1 NIPBL EIF3M MED12 DYNC1H1 GOLGA4 RBM34 VCP PTCD3 | 8.07e-08 | 1353 | 187 | 25 | 29467282 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ANK1 ANK3 PPFIA1 POLR2B NUMA1 CHD9 MEI1 TRANK1 MDN1 CROCC2 ATM MED12 RBM34 ZNF687 ZNF292 | 9.33e-08 | 497 | 187 | 15 | 36774506 |
| Pubmed | RAPGEF6 RICTOR SRSF11 CWC22 ANKRD27 ITPR1 PACS1 LIG3 ZNHIT6 DST TSR1 CASKIN2 DROSHA MTIF2 TBK1 HLTF QSER1 | 9.88e-08 | 650 | 187 | 17 | 38777146 | |
| Pubmed | 9.97e-08 | 104 | 187 | 8 | 9205841 | ||
| Pubmed | RANBP2 COPA NUMA1 CHD4 HUWE1 DST MDN1 TSR1 ANAPC1 ACIN1 ATM NIPBL MED12 DYNC1H1 RBM34 VCP PTCD3 | 1.05e-07 | 653 | 187 | 17 | 22586326 | |
| Pubmed | ANK2 ANK3 PDK1 SYNE1 PPFIA1 POLR2B RICTOR RSU1 ITPR1 ITPR2 USP10 THADA MED4 MDN1 AKAP9 ARHGEF10 TSR1 CASKIN2 MAP4K5 MTIF2 ATM GOLGA4 PUS7 RBM34 VCP PTCD3 | 1.27e-07 | 1487 | 187 | 26 | 33957083 | |
| Pubmed | RANBP2 TBC1D30 CNOT10 SYNE1 PPFIA1 POLR2B ARHGEF12 RICTOR USP10 MED4 MAN1A2 DST MDN1 DIMT1 TSR1 ANAPC1 DROSHA HLTF MIOS CRYBG1 CHD6 NIPBL EIF3M MED12 ZNF687 PTCD3 | 1.45e-07 | 1497 | 187 | 26 | 31527615 | |
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 1.53e-07 | 3 | 187 | 3 | 33410423 | |
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 1.53e-07 | 3 | 187 | 3 | 34289389 | |
| Pubmed | KNTC1 RAPGEF6 CNOT10 SMC1A PPFIA1 RICTOR RSU1 USP10 DST AKAP9 ANAPC1 TBK1 TRAPPC14 TRAPPC9 | 1.58e-07 | 446 | 187 | 14 | 24255178 | |
| Pubmed | PPFIA1 POLR2B KAT6A RNF213 CHD9 RICTOR CHD4 PPFIA3 JAK1 THADA ZNHIT6 DIMT1 EML5 ANAPC1 DROSHA MTIF2 TBK1 LRP1 LONRF3 VCP ZNF687 PTCD3 | 1.74e-07 | 1116 | 187 | 22 | 31753913 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | COPA SMC1A POLR2B KAT6A NUMA1 CHD4 USP10 LIG3 MED4 MDN1 DIMT1 TSR1 PIK3C3 DROSHA MIOS ACIN1 MED12 RBM34 | 1.74e-07 | 759 | 187 | 18 | 35915203 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 COPA SYNE1 SMC1A POLR2B NUMA1 SRSF11 CHD4 PSMD11 HUWE1 ITPR2 LIG3 DST MDN1 TBK1 XPNPEP3 ACIN1 LYN NIPBL DYNC1H1 VCP | 1.77e-07 | 1024 | 187 | 21 | 24711643 |
| Pubmed | CNOT10 KAT6A PSMD11 JAK1 STK10 THADA ZNHIT6 MDN1 AKAP9 VILL CASKIN2 CROCC2 ROCK1 FGD6 EIF3M RBM34 VCP | 2.24e-07 | 689 | 187 | 17 | 36543142 | |
| Pubmed | RANBP2 PSAT1 COPA SMC1A POLR2B NUMA1 CHD9 SRSF11 CHD4 PSMD11 HUWE1 USP10 LIG3 MED4 DIMT1 AKAP9 TSR1 TBK1 ACIN1 LYN MED12 DYNC1H1 VCP | 2.88e-07 | 1247 | 187 | 23 | 27684187 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RANBP2 COPA STAG1 ADGRB3 ARHGEF12 SHOC2 ITPR1 USP10 MTIF2 MIOS CHD6 KCNT1 TRAPPC9 VCP | 3.37e-07 | 475 | 187 | 14 | 31040226 |
| Pubmed | CEP104 STK36 ABCA13 NUMA1 ARHGEF12 CWC22 STK10 TRIM11 DST MIOS DYNC1H1 | 4.53e-07 | 284 | 187 | 11 | 29459677 | |
| Pubmed | KNTC1 STK36 TBC1D30 SMC1A RNF213 RICTOR TMEM200A THADA KAZN FGD6 MAML3 MED12 TRAPPC9 PUS7 | 5.26e-07 | 493 | 187 | 14 | 15368895 | |
| Pubmed | 5.26e-07 | 129 | 187 | 8 | 23022380 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ANK1 TBC1D30 RNF213 HUWE1 PPFIA3 ITPR2 LIG3 CCDC198 DST MDN1 DROSHA TBK1 CHD6 KAZN ATM LYN DYNC1H1 | 5.61e-07 | 736 | 187 | 17 | 29676528 |
| Pubmed | GPAA1 COPA PPFIA1 POLR2B NUMA1 SRSF11 PSMD11 LARS2 SHOC2 JAK1 USP10 DST TSR1 PIK3C3 TBK1 FTL MICA LYN NIPBL EIF3M DYNC1H1 RBM34 VCP | 5.69e-07 | 1297 | 187 | 23 | 33545068 | |
| Pubmed | ANK3 STAG1 PSMD11 HUWE1 ANKRD27 MED4 ZNHIT6 MAN1A2 DST DROSHA LRP1 ROCK1 FTL CHD6 DYNC1H1 | 8.38e-07 | 591 | 187 | 15 | 15231748 | |
| Pubmed | COPA SMC1A POLR2B NUMA1 RNF213 RICTOR CHD4 RSU1 JAK1 USP10 DIMT1 ARHGEF10 TSR1 TBK1 DYNC1H1 | 1.03e-06 | 601 | 187 | 15 | 33658012 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 PPFIA1 RICTOR SRSF11 BCAR1 ANKRD27 ARFGEF3 DST MDN1 AKAP9 ARHGEF10 CASKIN2 PIK3C3 CNKSR3 TRAPPC14 FGD6 TRAPPC9 GOLGA4 | 1.07e-06 | 861 | 187 | 18 | 36931259 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CNOT10 NUMA1 CHD9 CHD4 CWC22 LIG3 MED4 MDN1 ANAPC1 NLRC5 ACIN1 NIPBL DYNC1H1 ZNF687 | 1.32e-06 | 533 | 187 | 14 | 30554943 |
| Pubmed | RANBP2 GPAA1 COPA CNOT10 CNTRL RNF213 CHD4 PSMD11 HUWE1 ANKRD27 ITPR1 ITPR2 BPNT2 MED4 MAN1A2 MDN1 PIK3C3 HLTF FTL MED12 DYNC1H1 | 1.48e-06 | 1168 | 187 | 21 | 19946888 | |
| Pubmed | 1.52e-06 | 5 | 187 | 3 | 11782428 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.59e-06 | 104 | 187 | 7 | 31240132 | |
| Pubmed | RANBP2 ANK2 ANK3 COPA SMC1A PPFIA1 NUMA1 ARHGEF12 RICTOR DST MAP4K5 ROCK1 MED12 DYNC1H1 GOLGA4 VCP | 1.62e-06 | 708 | 187 | 16 | 39231216 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ABCA13 ENPP2 NTRK2 PPFIA1 RNF213 ZSWIM6 ITPR1 ARFGEF3 TRANK1 NLRC5 CRYBG1 POMK EIF3M GOLGA4 | 1.98e-06 | 552 | 187 | 14 | 10737800 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RANBP2 PSAT1 SMC1A NUMA1 CHD4 HUWE1 PPFIA3 DST DROSHA ACIN1 DYNC1H1 VCP PTCD3 | 2.13e-06 | 477 | 187 | 13 | 31300519 |
| Pubmed | CNOT10 POLR2B HUWE1 HAUS2 LIG3 MED4 DST TSR1 TBK1 ROCK1 CHD6 EIF3M MED12 ZNF687 PTCD3 | 2.45e-06 | 645 | 187 | 15 | 25281560 | |
| Pubmed | In vitro loading of human cohesin on DNA by the human Scc2-Scc4 loader complex. | 3.02e-06 | 6 | 187 | 3 | 22628566 | |
| Pubmed | The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair. | 3.02e-06 | 6 | 187 | 3 | 34553755 | |
| Pubmed | RANBP2 NRAP ANK2 SYNE1 SMC1A CHD4 RSU1 DST AKAP9 DROSHA TBK1 LONRF3 VCP | 3.33e-06 | 497 | 187 | 13 | 23414517 | |
| Pubmed | NUMA1 SRSF11 PACS1 LIG3 DST MAP4K5 ACIN1 NIPBL DYNC1H1 GOLGA4 PTCD3 | 4.50e-06 | 360 | 187 | 11 | 33111431 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 POLR2B NUMA1 RICTOR CHD4 HUWE1 ITPR1 ITPR2 USP10 ANAPC1 MIOS ZNF687 | 5.26e-06 | 440 | 187 | 12 | 34244565 |
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 5.27e-06 | 7 | 187 | 3 | 7495297 | |
| Pubmed | ANK2 COPA PPFIA1 POLR2B ARHGEF12 PSMD11 HUWE1 USP10 MED4 ZNHIT6 DIMT1 TSR1 ANAPC1 LRP1 EIF3M GPRASP2 RBM34 PTCD3 | 5.72e-06 | 971 | 187 | 18 | 33306668 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | STAG1 SMC1A KAT6A NUMA1 CHD9 CHD4 LIG3 TSR1 HLTF CHD6 QSER1 NIPBL RBM34 ZNF292 | 6.00e-06 | 608 | 187 | 14 | 36089195 |
| Pubmed | CEP104 ADGRB3 SHOC2 CWC22 ANKRD27 USP10 TRANK1 DST TSR1 CASKIN2 CARNS1 KCNT1 ZNF687 | 6.53e-06 | 529 | 187 | 13 | 14621295 | |
| Pubmed | TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14. | 6.62e-06 | 23 | 187 | 4 | 29581427 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ANK3 PPFIA1 RICTOR JAK1 STK10 PACS1 DST CASKIN2 MAP4K5 ROCK1 LYN | 6.96e-06 | 377 | 187 | 11 | 38117590 |
| Pubmed | 7.91e-06 | 24 | 187 | 4 | 33705438 | ||
| Pubmed | A potential role for human cohesin in mitotic spindle aster assembly. | 8.40e-06 | 8 | 187 | 3 | 11590136 | |
| Pubmed | OR5T3 PSAT1 ABHD2 RICTOR HPSE2 RSU1 ITPR1 PKNOX2 PIK3C3 ANAPC1 CARD9 VWA5A NIPBL TRAPPC9 DEUP1 NLRP8 | 9.43e-06 | 814 | 187 | 16 | 23251661 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CHD4 BCAR1 RSU1 CDK10 ITPR2 JAK1 STK10 CCDC198 DST AKAP9 ANAPC1 MAP4K5 TBK1 MAPK8 LYN EIF3M ZNF687 | 9.52e-06 | 910 | 187 | 17 | 36736316 |
| Pubmed | ANK3 SMC1A PPFIA1 ARHGEF12 PSMD11 ARFGEF3 CASKIN2 PIK3C3 TBK1 | 9.56e-06 | 251 | 187 | 9 | 29778605 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 1.09e-05 | 139 | 187 | 7 | 25476789 | |
| Pubmed | CEP104 KNTC1 RGPD2 RANBP2 ANK2 COPA STAG1 SYNE1 PPFIA1 CNTRL NUMA1 SRSF11 CHD4 DST MDN1 CNKSR3 ACIN1 CFAP74 CHD6 ATM NIPBL ZNF292 | 1.13e-05 | 1442 | 187 | 22 | 35575683 | |
| Pubmed | KNTC1 PPFIA1 POLR2B RNF213 HUWE1 ITPR2 ARHGEF10 ANAPC1 MIOS ROCK1 CHD6 QSER1 EIF3M GOLGA4 ZNF687 | 1.13e-05 | 733 | 187 | 15 | 34672954 | |
| Pubmed | 1.15e-05 | 195 | 187 | 8 | 19454010 | ||
| Pubmed | 1.43e-05 | 145 | 187 | 7 | 28846114 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.50e-05 | 146 | 187 | 7 | 23892456 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | CNOT10 SHOC2 CWC22 DST ACIN1 QSER1 NIPBL MED12 RBM34 VCP PTCD3 | 1.52e-05 | 410 | 187 | 11 | 26949251 |
| Pubmed | STK36 COPA SYNE1 SMC1A POLR2B CNTRL CHD4 PPFIA3 ITPR1 LIG3 HLTF CHD6 EIF3M DYNC1H1 ZNF687 | 1.57e-05 | 754 | 187 | 15 | 35906200 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | STAG1 SMC1A POLR2B RNF213 ITPR2 JAK1 LIG3 ACIN1 MED12 ZNF687 | 1.76e-05 | 341 | 187 | 10 | 32971831 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.76e-05 | 271 | 187 | 9 | 32433965 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.79e-05 | 10 | 187 | 3 | 22159418 | |
| Pubmed | 1.81e-05 | 272 | 187 | 9 | 31010829 | ||
| Pubmed | 1.87e-05 | 151 | 187 | 7 | 17043677 | ||
| Pubmed | RAPGEF6 ANK3 PDK1 PPFIA1 RICTOR STK10 PACS1 DST ARHGEF10 MAP4K5 ROCK1 | 1.94e-05 | 421 | 187 | 11 | 36976175 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 2.03e-05 | 153 | 187 | 7 | 26365490 | |
| Pubmed | 2.03e-05 | 153 | 187 | 7 | 10718198 | ||
| Pubmed | 2.07e-05 | 103 | 187 | 6 | 32744500 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | STK36 RAPGEF6 ANK3 NUMA1 BCAR1 PKNOX2 STK10 MAP4K5 ATM DYNC1H1 SOS2 | 2.36e-05 | 430 | 187 | 11 | 35044719 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 2.40e-05 | 157 | 187 | 7 | 30686591 | |
| Pubmed | RAPGEF6 SALL3 ANK3 ABHD2 PPFIA1 POLR2B CNTRL RICTOR HUWE1 ITPR1 PACS1 EML5 VILL TSR1 ACIN1 CRYBG1 ROCK1 QSER1 | 2.49e-05 | 1084 | 187 | 18 | 11544199 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | RANBP2 SMC1A POLR2B HUWE1 CDK10 MED4 AKAP9 DROSHA ACIN1 ROCK1 MAPK8 EIF3M MED12 RBM34 | 2.65e-05 | 695 | 187 | 14 | 23602568 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RANBP2 COPA SMC1A POLR2B NUMA1 CHD4 HUWE1 PPWD1 RSU1 USP10 DIMT1 TSR1 XPNPEP3 HLTF NIPBL EIF3M DYNC1H1 GOLGA4 PUS7 VCP PTCD3 | 2.71e-05 | 1415 | 187 | 21 | 28515276 |
| Pubmed | 2.83e-05 | 288 | 187 | 9 | 23383273 | ||
| Pubmed | CHD chromatin remodelling enzymes and the DNA damage response. | 2.88e-05 | 2 | 187 | 2 | 23954449 | |
| Pubmed | A large Canadian cohort provides insights into the genetic architecture of human hair colour. | 2.88e-05 | 2 | 187 | 2 | 34737440 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 15201137 | ||
| Pubmed | Cholinergic augmentation of insulin release requires ankyrin-B. | 2.88e-05 | 2 | 187 | 2 | 20234002 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 14722080 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 2.88e-05 | 2 | 187 | 2 | 23582047 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 26807827 | ||
| Pubmed | NuMA1 promotes axon initial segment assembly through inhibition of endocytosis. | 2.88e-05 | 2 | 187 | 2 | 31727776 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 11449000 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 25173936 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 31091164 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 22496420 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 2.88e-05 | 2 | 187 | 2 | 19120126 | |
| Pubmed | Phenotypes and genotypes in individuals with SMC1A variants. | 2.88e-05 | 2 | 187 | 2 | 28548707 | |
| Interaction | RAPGEF5 interactions | 1.21e-06 | 60 | 184 | 7 | int:RAPGEF5 | |
| Interaction | EEF1AKMT3 interactions | KNTC1 CNOT10 SMC1A ARHGEF12 RICTOR HUWE1 NR1D1 ANKRD27 ZNHIT6 MDN1 ARHGEF10 ANAPC1 TBK1 MAPK8 GPAT2 | 1.34e-06 | 364 | 184 | 15 | int:EEF1AKMT3 |
| Interaction | BMI1 interactions | RANBP2 SYNE1 NUMA1 CHD4 CFAP141 PPWD1 ITPR2 ARFGEF3 DST AKAP9 CASKIN2 DROSHA NLRC5 ACIN1 ATM EIF3M MED12 DYNC1H1 ZNF687 PTCD3 | 2.72e-06 | 659 | 184 | 20 | int:BMI1 |
| Interaction | HERC2 interactions | CEP104 ANK2 COPA PPFIA1 ARHGEF12 SRSF11 PSMD11 ITPR2 MED4 DST AKAP9 LRRC31 TBK1 MIOS FTL C2CD6 EIF3M | 3.89e-06 | 503 | 184 | 17 | int:HERC2 |
| Interaction | UBXN6 interactions | KNTC1 COPA ARHGEF12 RICTOR ZNHIT6 DST MDN1 ARHGEF10 ANAPC1 TXNRD3 MAPK8 GPAT2 VCP | 9.58e-06 | 325 | 184 | 13 | int:UBXN6 |
| Interaction | OTUD7A interactions | 1.46e-05 | 58 | 184 | 6 | int:OTUD7A | |
| Interaction | DIRAS3 interactions | ANK3 PPFIA1 RICTOR HUWE1 DST PIK3C3 MAP4K5 MTIF2 LYN GOLGA4 VCP | 3.03e-05 | 262 | 184 | 11 | int:DIRAS3 |
| Interaction | CDC5L interactions | STK36 RANBP2 COPA SYNE1 SMC1A PPFIA1 RICTOR CHD4 PSMD11 CFAP141 HUWE1 PPWD1 CWC22 USP10 DST MDN1 AKAP9 ANAPC1 HLTF NIPBL DYNC1H1 | 3.73e-05 | 855 | 184 | 21 | int:CDC5L |
| Interaction | FBXO22 interactions | ANK1 ANK3 PPFIA1 POLR2B NUMA1 CHD9 BCAR1 MEI1 TRANK1 MDN1 CROCC2 ATM MED12 RBM34 ZNF687 ZNF292 | 3.79e-05 | 540 | 184 | 16 | int:FBXO22 |
| Interaction | USP15 interactions | ANK3 SMC1A KAT6A RNF213 CHD4 PSMD11 HUWE1 USP10 TRIM11 MED4 TSR1 ANAPC1 CARD9 TBK1 DYNC1H1 VCP | 4.32e-05 | 546 | 184 | 16 | int:USP15 |
| Interaction | KCNA3 interactions | RANBP2 ANK2 ANK3 COPA ABCA13 NTRK2 SMC1A PPFIA1 NUMA1 ARHGEF12 RNF213 CHD9 RICTOR HELQ DST MAP4K5 ROCK1 MED12 DYNC1H1 GOLGA4 VCP | 4.88e-05 | 871 | 184 | 21 | int:KCNA3 |
| Interaction | EED interactions | KNTC1 RANBP2 PSAT1 COPA STAG1 SMC1A POLR2B NUMA1 RICTOR CHD4 PSMD11 HUWE1 PPWD1 CWC22 USP10 LIG3 THADA MAN1A2 DIMT1 VILL DROSHA TBK1 ACIN1 FTL NIPBL EIF3M DYNC1H1 VCP ZNF687 | 4.98e-05 | 1445 | 184 | 29 | int:EED |
| Interaction | TNIK interactions | ANK2 ANK3 SYNE1 BEX1 NTRK2 HUWE1 USP10 DST AKAP9 LYN PCDH8 DYNC1H1 GOLGA4 | 5.04e-05 | 381 | 184 | 13 | int:TNIK |
| Interaction | MEX3A interactions | ANK1 COPA KAT6A NUMA1 CHD4 HUWE1 BCAR1 LARS2 JAK1 DST ARHGEF10 DYNC1H1 VCP | 5.46e-05 | 384 | 184 | 13 | int:MEX3A |
| Interaction | PCNT interactions | 7.72e-05 | 241 | 184 | 10 | int:PCNT | |
| Interaction | BRD1 interactions | POLR2B KAT6A NUMA1 RICTOR CHD4 DIMT1 ANAPC1 MTIF2 TBK1 LRP1 QSER1 ZNF687 | 7.99e-05 | 344 | 184 | 12 | int:BRD1 |
| Interaction | SIGLECL1 interactions | 8.07e-05 | 113 | 184 | 7 | int:SIGLECL1 | |
| Interaction | HMGN5 interactions | 8.70e-05 | 154 | 184 | 8 | int:HMGN5 | |
| Interaction | HECTD1 interactions | COPA SMC1A POLR2B KAT6A NUMA1 CHD4 HUWE1 USP10 LIG3 MED4 MDN1 DIMT1 ARHGEF10 LRRC31 TSR1 PIK3C3 DROSHA MIOS ACIN1 MED12 RBM34 VCP | 9.69e-05 | 984 | 184 | 22 | int:HECTD1 |
| Interaction | SUMO2 interactions | RANBP2 COPA SMC1A NUMA1 RNF213 CHD4 HUWE1 DST MDN1 TSR1 ANAPC1 TBK1 ACIN1 NIPBL DYNC1H1 VCP | 1.09e-04 | 591 | 184 | 16 | int:SUMO2 |
| Interaction | CCDC8 interactions | RANBP2 COPA NTRK2 SMC1A NUMA1 CHD4 HUWE1 ITPR2 LIG3 DST MDN1 TBK1 LYN NIPBL GPRASP2 DYNC1H1 VCP | 1.13e-04 | 656 | 184 | 17 | int:CCDC8 |
| Interaction | H2AX interactions | RANBP2 BEX1 SMC1A NUMA1 CHD4 HUWE1 BCAR1 LIG3 MDN1 HLTF ATM MAPK8 NIPBL VCP ZNF687 PTCD3 | 1.14e-04 | 593 | 184 | 16 | int:H2AX |
| Interaction | CTDP1 interactions | 1.24e-04 | 207 | 184 | 9 | int:CTDP1 | |
| Interaction | NANOG interactions | RANBP2 SALL3 STAG1 POLR2B CHD4 PSMD11 HUWE1 MDN1 AKAP9 TSR1 HLTF QSER1 MED12 PTCD3 | 1.41e-04 | 481 | 184 | 14 | int:NANOG |
| Interaction | BANK1 interactions | 1.55e-04 | 12 | 184 | 3 | int:BANK1 | |
| Interaction | CHL1 interactions | 1.55e-04 | 12 | 184 | 3 | int:CHL1 | |
| Interaction | SIRT7 interactions | RANBP2 COPA NUMA1 CHD4 HUWE1 DST MDN1 TSR1 ANAPC1 ACIN1 FTL ATM NIPBL MED12 DYNC1H1 RBM34 VCP PTCD3 | 1.66e-04 | 744 | 184 | 18 | int:SIRT7 |
| Interaction | POLR1G interactions | SMC1A POLR2B KAT6A NUMA1 CHD9 HUWE1 LIG3 MED4 MDN1 TSR1 MTIF2 NIPBL RBM34 ZNF292 | 1.67e-04 | 489 | 184 | 14 | int:POLR1G |
| Interaction | PINK1 interactions | RANBP2 PSAT1 SMC1A NUMA1 RICTOR CHD4 PSMD11 HUWE1 PPFIA3 DST DROSHA DHRS9 ACIN1 FTL DYNC1H1 VCP PTCD3 | 1.70e-04 | 679 | 184 | 17 | int:PINK1 |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.43e-05 | 115 | 124 | 7 | 769 | |
| GeneFamily | Sterile alpha motif domain containing | 3.16e-05 | 88 | 124 | 6 | 760 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.39e-04 | 3 | 124 | 2 | 297 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.09e-03 | 66 | 124 | 4 | 722 | |
| GeneFamily | Cohesin complex | 1.27e-03 | 8 | 124 | 2 | 1060 | |
| GeneFamily | Ankyrin repeat domain containing | 1.41e-03 | 242 | 124 | 7 | 403 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 PHF20 STAG1 PPFIA1 POLR2B KAT6A CHD9 LARS2 SHOC2 C2CD2 ITPR1 TDRD7 STK10 DST MDN1 AKAP9 ARHGEF10 PIK3C3 MAP4K5 MTIF2 HLTF ROCK1 KAZN MAPK8 LYN NIPBL GOLGA4 ZNF292 SOS2 | 2.51e-12 | 856 | 185 | 29 | M4500 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | KNTC1 RAPGEF6 SMC1A CNTRL NUMA1 ARHGEF12 RICTOR BCAR1 DST ROCK1 FGD6 DYNC1H1 | 1.95e-08 | 199 | 185 | 12 | M5893 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RANBP2 RAPGEF6 PHF20 HTR7 SYNE1 POLR2B CNTRL KAT6A NUMA1 RNF213 RICTOR HUWE1 ITPR1 ITPR2 JAK1 STK10 PACS1 TRANK1 MAN1A2 AKAP9 VWA5A CD101 TBK1 NLRC5 CRYBG1 ROCK1 ATM NIPBL DYNC1H1 ZNF292 | 2.09e-07 | 1492 | 185 | 30 | M40023 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | RAPGEF6 STAG1 PDK1 SYNE1 ARHGEF12 PPWD1 TMTC4 MTIF2 HLTF ATM | 7.96e-07 | 184 | 185 | 10 | M9005 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STAG1 PPFIA1 KAT6A CHD9 LARS2 C2CD2 TDRD7 DST MDN1 AKAP9 PIK3C3 MAP4K5 LYN GOLGA4 ZNF292 | 1.23e-06 | 466 | 185 | 15 | M13522 |
| Coexpression | GSE22886_NAIVE_VS_MEMORY_TCELL_UP | 1.04e-05 | 194 | 185 | 9 | M4416 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 1.73e-05 | 158 | 185 | 8 | M372 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 2.47e-05 | 166 | 185 | 8 | M8129 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP | 3.46e-05 | 174 | 185 | 8 | M6296 | |
| Coexpression | PILON_KLF1_TARGETS_UP | KNTC1 ANK3 EXD1 PPFIA1 HUWE1 BCAR1 SHOC2 ADAM12 C2CD2 EDNRB TBK1 MIOS LGR6 | 6.37e-05 | 503 | 185 | 13 | M2226 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 RAPGEF6 ENPP2 PPFIA1 SRSF11 PPWD1 ITPR1 ITPR2 TDRD7 TBK1 HLTF ATM QSER1 NIPBL GOLGA4 | 6.97e-05 | 656 | 185 | 15 | M18979 |
| Coexpression | GSE3982_MAST_CELL_VS_BCELL_DN | 8.30e-05 | 197 | 185 | 8 | M5437 | |
| Coexpression | GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN | 8.90e-05 | 199 | 185 | 8 | M5726 | |
| Coexpression | GSE27786_LSK_VS_CD4_TCELL_DN | 9.22e-05 | 200 | 185 | 8 | M4747 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP | 9.22e-05 | 200 | 185 | 8 | M7172 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP | 9.22e-05 | 200 | 185 | 8 | M4323 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.13e-04 | 206 | 185 | 8 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.21e-04 | 208 | 185 | 8 | MM581 | |
| Coexpression | PILON_KLF1_TARGETS_UP | KNTC1 ANK3 EXD1 PPFIA1 HUWE1 BCAR1 SHOC2 ADAM12 C2CD2 EDNRB TBK1 MIOS LGR6 | 1.32e-04 | 541 | 185 | 13 | MM1061 |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_DN | 1.46e-04 | 160 | 185 | 7 | M11011 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 1.47e-04 | 38 | 185 | 4 | M1751 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | SALL3 NRCAM NTRK2 SMC1A ADGRB3 SRSF11 LARS2 CWC22 AKAP9 EML5 MTIF2 ROCK1 CFAP74 FGD6 NIPBL MAML3 GOLGA4 | 1.70e-06 | 498 | 184 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PHF20 SMC1A POLR2B KAT6A ARHGEF12 CHD9 CHD4 LARS2 ZNHIT6 EML5 NDUFAF7 MTIF2 TBK1 CFAP74 MAML3 DYNC1H1 GOLGA4 ZNF292 | 4.54e-06 | 595 | 184 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | FILIP1 ANK2 ANK3 TBC1D30 NRCAM ABHD2 NTRK2 ADGRB3 HUWE1 ADAM12 HAUS2 EDNRB JAK1 LIG3 MAN1A2 AKAP9 ANAPC1 SLITRK6 MAPK8 VCP | 2.99e-05 | 818 | 184 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | RAPGEF6 SMC1A POLR2B KAT6A CHD9 SRSF11 ITPR2 THADA ZNHIT6 MTIF2 TBK1 CFAP74 QSER1 FGD6 MAML3 ZNF292 | 3.43e-05 | 564 | 184 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SMC1A POLR2B KAT6A ARHGEF12 CHD9 SRSF11 TMEM200A ZNHIT6 AKAP9 NDUFAF7 MTIF2 TBK1 QSER1 NIPBL MAML3 GPRASP2 ZNF292 | 3.56e-05 | 629 | 184 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | RAPGEF6 PDK1 RICTOR ITPR2 JAK1 THADA MDN1 EML5 NLRC5 ATM MED12 ZNF292 | 3.89e-05 | 336 | 184 | 12 | GSM538413_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.70e-05 | 192 | 184 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PHF20 ANK2 NRCAM SMC1A CNTRL VEPH1 CHD9 SRSF11 CHD4 LARS2 PPWD1 PKNOX2 MDN1 DIMT1 AKAP9 EML5 MTIF2 ROCK1 CFAP74 ATM QSER1 TRAPPC14 MAPK8 NIPBL ZNF292 | 8.92e-05 | 1257 | 184 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | RANBP2 SALL3 ANK2 NRCAM NTRK2 ADGRB3 SRSF11 ZSWIM6 LARS2 CWC22 CDK10 EDNRB MDN1 AKAP9 EML5 ROCK1 CHD6 SLITRK6 TRAPPC14 GPRASP2 DEUP1 | 1.29e-04 | 983 | 184 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PHF20 ANK2 NRCAM SMC1A CNTRL VEPH1 CHD9 SRSF11 CHD4 LARS2 PPWD1 CWC22 PKNOX2 MDN1 DIMT1 AKAP9 EML5 MTIF2 ROCK1 CFAP74 ATM QSER1 TRAPPC14 MAPK8 NIPBL DEUP1 ZNF292 | 1.51e-04 | 1459 | 184 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ANK3 SYNE1 RNF213 RICTOR SRSF11 AKAP9 NLRC5 ATM GOLGA4 ZNF292 | 1.31e-08 | 199 | 187 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RNF213 SRSF11 AKAP9 ACIN1 ROCK1 ATM NIPBL DYNC1H1 GOLGA4 ZNF292 | 1.37e-08 | 200 | 187 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.76e-08 | 171 | 187 | 9 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-07 | 193 | 187 | 9 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-07 | 193 | 187 | 9 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-07 | 194 | 187 | 9 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.60e-07 | 197 | 187 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.74e-07 | 199 | 187 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.74e-07 | 199 | 187 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.87e-07 | 175 | 187 | 8 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.87e-07 | 175 | 187 | 8 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.01e-06 | 181 | 187 | 8 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.30e-06 | 187 | 187 | 8 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 189 | 187 | 8 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-06 | 191 | 187 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.58e-06 | 192 | 187 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.64e-06 | 193 | 187 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.69e-06 | 135 | 187 | 7 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 195 | 187 | 8 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.91e-06 | 197 | 187 | 8 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.99e-06 | 198 | 187 | 8 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 198 | 187 | 8 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-06 | 198 | 187 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.99e-06 | 198 | 187 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.99e-06 | 198 | 187 | 8 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 198 | 187 | 8 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.99e-06 | 198 | 187 | 8 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 199 | 187 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.06e-06 | 199 | 187 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 187 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.42e-06 | 156 | 187 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 4.91e-06 | 59 | 187 | 5 | 74590437b1d9a2a8fe56d79b2e66803528b81298 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.67e-06 | 162 | 187 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 167 | 187 | 7 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.72e-06 | 173 | 187 | 7 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.39e-06 | 175 | 187 | 7 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.75e-06 | 176 | 187 | 7 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.75e-06 | 176 | 187 | 7 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 177 | 187 | 7 | 9c7c6824b9011363851f084a500d665f025b026e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 177 | 187 | 7 | 2bf639e9e801e5144462ffc957f5739e0dfcd500 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.01e-05 | 177 | 187 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 178 | 187 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 179 | 187 | 7 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 181 | 187 | 7 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.23e-05 | 121 | 187 | 6 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.26e-05 | 183 | 187 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-05 | 123 | 187 | 6 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.40e-05 | 186 | 187 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.50e-05 | 188 | 187 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.55e-05 | 189 | 187 | 7 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.55e-05 | 189 | 187 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.60e-05 | 190 | 187 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-05 | 190 | 187 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 191 | 187 | 7 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 191 | 187 | 7 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 187 | 7 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 191 | 187 | 7 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 192 | 187 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.71e-05 | 192 | 187 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-05 | 193 | 187 | 7 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.77e-05 | 193 | 187 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 193 | 187 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.77e-05 | 193 | 187 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 194 | 187 | 7 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 194 | 187 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.83e-05 | 194 | 187 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.83e-05 | 194 | 187 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 195 | 187 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 195 | 187 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 195 | 187 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.96e-05 | 196 | 187 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.96e-05 | 196 | 187 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 196 | 187 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.02e-05 | 197 | 187 | 7 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-05 | 197 | 187 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.02e-05 | 197 | 187 | 7 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 198 | 187 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.09e-05 | 198 | 187 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.16e-05 | 199 | 187 | 7 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.16e-05 | 199 | 187 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.16e-05 | 199 | 187 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.16e-05 | 199 | 187 | 7 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.16e-05 | 199 | 187 | 7 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.16e-05 | 199 | 187 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.16e-05 | 199 | 187 | 7 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 199 | 187 | 7 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-05 | 199 | 187 | 7 | a816b0eed80530113b7e720bbd2311a544ed8ed1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 199 | 187 | 7 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.16e-05 | 199 | 187 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.23e-05 | 200 | 187 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.23e-05 | 200 | 187 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.23e-05 | 200 | 187 | 7 | 2441a36d363b799a4692aa697f969cda056c2d60 | |
| ToppCell | mLN-Mast_cell-Mast|mLN / Region, Cell class and subclass | 2.23e-05 | 200 | 187 | 7 | 81ea6e7a3940277751faf9097b30198159998c7b | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.23e-05 | 200 | 187 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | mLN-Mast_cell|mLN / Region, Cell class and subclass | 2.23e-05 | 200 | 187 | 7 | 9a5f1d99d8d160923d4d0fbbf9ad48a26f8a4fad | |
| ToppCell | mLN-(7)_Mast_cell-(70)_Mast|mLN / shred on region, Cell_type, and subtype | 2.23e-05 | 200 | 187 | 7 | a6c258cae678be581b1d85cf3446c65c34b13499 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.23e-05 | 200 | 187 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.73e-07 | 49 | 103 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-04 | 50 | 103 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Thimerosal | PHF20 ANK2 STAG1 PDK1 SMC1A KAT6A CDC20B ARHGEF12 CHD9 CHD4 SHOC2 C2CD2 EDNRB TDRD7 ARFGEF3 USP10 DST AKAP9 EML5 ARHGEF10 MAP4K5 MICA ATM LGR6 MAPK8 FGD6 NIPBL VCP | 5.17e-07 | 1199 | 186 | 28 | ctd:D013849 |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | ANK3 ADAM12 PACS1 BPNT2 AKAP9 NDUFAF7 ACIN1 LONRF3 TRAPPC14 LYN ZNF292 | 5.46e-07 | 192 | 186 | 11 | 7280_DN |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A | PDK1 ARHGEF12 PPFIA3 ITPR1 BPNT2 XPNPEP3 CRYBG1 KAZN TRAPPC14 LYN EIF3M | 7.41e-07 | 198 | 186 | 11 | 7266_DN |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 3.53e-06 | 188 | 186 | 10 | 6186_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 4.46e-06 | 193 | 186 | 10 | 4321_DN | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A | CEP104 PHF20 NTRK2 SMC1A CNTRL MAN1A2 XPNPEP3 ATM MAPK8 EIF3M | 4.46e-06 | 193 | 186 | 10 | 4118_DN |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; HL60; HT_HG-U133A | CEP104 PHF20 NRCAM COPA NR1D1 CDK10 PRELP QSER1 TRAPPC14 MAPK8 | 5.11e-06 | 196 | 186 | 10 | 2942_DN |
| Drug | Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 5.35e-06 | 197 | 186 | 10 | 2752_UP | |
| Drug | Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | STAG1 SYNE1 SMC1A ARHGEF12 ADAM12 CDK10 ITPR2 DIMT1 MAP4K5 MAPK8 | 5.59e-06 | 198 | 186 | 10 | 4584_DN |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; PC3; HT_HG-U133A | NRCAM CYP3A5 HUWE1 ITPR2 TRANK1 MAN1A2 CCDC198 LRRC31 CARD9 WNT16 | 5.85e-06 | 199 | 186 | 10 | 3805_UP |
| Drug | Clorgyline | 1.03e-05 | 168 | 186 | 9 | ctd:D003010 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 2.05e-05 | 183 | 186 | 9 | 7498_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.14e-05 | 184 | 186 | 9 | 2321_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 2.64e-05 | 189 | 186 | 9 | 1171_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 2.87e-05 | 191 | 186 | 9 | 4283_DN | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.38e-05 | 195 | 186 | 9 | 7426_DN | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 3.38e-05 | 195 | 186 | 9 | 4799_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 3817_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 7182_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 4291_UP | |
| Drug | amitriptyline hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 3.52e-05 | 196 | 186 | 9 | 167_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 2119_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 3.52e-05 | 196 | 186 | 9 | 2035_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 3.81e-05 | 198 | 186 | 9 | 4464_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A | 3.81e-05 | 198 | 186 | 9 | 6332_DN | |
| Drug | 3-doxylandrostanol | 4.35e-05 | 9 | 186 | 3 | CID000189075 | |
| Drug | 1pzj | 7.15e-05 | 167 | 186 | 8 | CID000447976 | |
| Drug | 26-nor-25-doxylcholestanol | 8.44e-05 | 11 | 186 | 3 | CID000125890 | |
| Drug | AC1NSPXR | 8.44e-05 | 11 | 186 | 3 | CID005313815 | |
| Drug | delta 8-THC | 8.44e-05 | 11 | 186 | 3 | CID000002977 | |
| Drug | dimethyloxalylglycine; Up 200; 1000uM; PC3; HG-U133A | 8.79e-05 | 172 | 186 | 8 | 584_UP | |
| Drug | xestospongin C | 1.12e-04 | 12 | 186 | 3 | ctd:C511704 | |
| Drug | PD-V | 1.12e-04 | 12 | 186 | 3 | CID000444615 | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 1.16e-04 | 179 | 186 | 8 | 4452_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; HL60; HT_HG-U133A | 1.25e-04 | 181 | 186 | 8 | 2136_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.30e-04 | 182 | 186 | 8 | 3887_DN | |
| Drug | mancozeb | 1.44e-04 | 13 | 186 | 3 | CID003034368 | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.51e-04 | 186 | 186 | 8 | 2426_DN | |
| Drug | Clioquinol | 1.53e-04 | 62 | 186 | 5 | ctd:D007464 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.75e-04 | 190 | 186 | 8 | 4322_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.88e-04 | 192 | 186 | 8 | 1266_DN | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.88e-04 | 192 | 186 | 8 | 6659_DN | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.88e-04 | 192 | 186 | 8 | 5620_UP | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.95e-04 | 193 | 186 | 8 | 2098_DN | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.95e-04 | 193 | 186 | 8 | 2764_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.95e-04 | 193 | 186 | 8 | 6678_UP | |
| Drug | Podophyllotoxin [518-28-5]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.95e-04 | 193 | 186 | 8 | 2540_DN | |
| Drug | iminophosphamide | 1.98e-04 | 3 | 186 | 2 | CID000134773 | |
| Drug | PHA-00846566E [724718-26-7]; Up 200; 10uM; PC3; HT_HG-U133A | 2.02e-04 | 194 | 186 | 8 | 7086_UP | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.02e-04 | 194 | 186 | 8 | 5049_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 2.02e-04 | 194 | 186 | 8 | 4319_DN | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.02e-04 | 194 | 186 | 8 | 2893_UP | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.02e-04 | 194 | 186 | 8 | 2433_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 2.02e-04 | 194 | 186 | 8 | 4141_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.02e-04 | 194 | 186 | 8 | 3779_DN | |
| Drug | Reserpine [50-55-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 4203_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 4980_DN | |
| Drug | Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 3519_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 3710_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 1665_DN | |
| Drug | SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 7054_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 2311_DN | |
| Drug | Epiandrosterone [481-29-8]; Down 200; 13.8uM; HL60; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 2444_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 3237_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.09e-04 | 195 | 186 | 8 | 4398_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A | 2.16e-04 | 196 | 186 | 8 | 1418_UP | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; HL60; HG-U133A | 2.16e-04 | 196 | 186 | 8 | 1620_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 2.16e-04 | 196 | 186 | 8 | 990_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.16e-04 | 196 | 186 | 8 | 6692_DN | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A | 2.16e-04 | 196 | 186 | 8 | 6309_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.16e-04 | 196 | 186 | 8 | 7329_DN | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A | 2.16e-04 | 196 | 186 | 8 | 4075_UP | |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; HL60; HG-U133A | 2.16e-04 | 196 | 186 | 8 | 1995_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.24e-04 | 197 | 186 | 8 | 2848_DN | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A | 2.24e-04 | 197 | 186 | 8 | 6890_UP | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.24e-04 | 197 | 186 | 8 | 7282_DN | |
| Drug | felodipine; Up 200; 10uM; MCF7; HG-U133A | 2.24e-04 | 197 | 186 | 8 | 337_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 2.24e-04 | 197 | 186 | 8 | 1180_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A | 2.24e-04 | 197 | 186 | 8 | 1441_UP | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.24e-04 | 197 | 186 | 8 | 7193_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 5829_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 2065_UP | |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; MCF7; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 4116_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 4343_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 5680_UP | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 6426_UP | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 5304_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 5087_UP | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 2791_UP | |
| Drug | Caffeic acid [3331-39-5]; Up 200; 22.2uM; HL60; HT_HG-U133A | 2.32e-04 | 198 | 186 | 8 | 3053_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.40e-04 | 199 | 186 | 8 | 5540_UP | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.40e-04 | 199 | 186 | 8 | 2872_DN | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A | 2.40e-04 | 199 | 186 | 8 | 5095_DN | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; HL60; HG-U133A | 2.40e-04 | 199 | 186 | 8 | 1580_DN | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.40e-04 | 199 | 186 | 8 | 5838_DN | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A | 2.40e-04 | 199 | 186 | 8 | 4533_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; HL60; HT_HG-U133A | 2.48e-04 | 200 | 186 | 8 | 1263_UP | |
| Drug | Racecadotril [81110-73-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.48e-04 | 200 | 186 | 8 | 5755_UP | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.48e-04 | 200 | 186 | 8 | 5403_DN | |
| Drug | Epiandrosterone [481-29-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.48e-04 | 200 | 186 | 8 | 5687_DN | |
| Disease | Schizophrenia | ANKK1 PSAT1 RAPGEF6 ANK3 HTR7 CYP3A5 ABCA13 NTRK2 CHD4 LARS2 ADAM12 PKNOX2 EML5 PIK3C3 LRP1 ATM MAPK8 PCDH8 MED12 | 3.25e-06 | 883 | 185 | 19 | C0036341 |
| Disease | Malignant neoplasm of breast | ANK1 ANK2 NRCAM SYNE1 BCAR1 ADAM12 HELQ EDNRB AKAP9 TMTC4 ASL NLRC5 ATM LGR6 LONRF3 FASTKD3 PCDH8 NIPBL EIF3M MED12 NLRP8 | 4.28e-06 | 1074 | 185 | 21 | C0006142 |
| Disease | Hypoxic Brain Damage | 3.91e-05 | 2 | 185 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 3.91e-05 | 2 | 185 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 3.91e-05 | 2 | 185 | 2 | C1527348 | |
| Disease | Anoxia of brain | 3.91e-05 | 2 | 185 | 2 | C0995195 | |
| Disease | Colorectal Carcinoma | SALL3 ANK2 NRCAM ABCA13 SYNE1 LIG3 ZNHIT6 AKAP9 WNT16 LRP1 ACIN1 C2CD6 LGR6 NLRP8 ZNF292 | 3.98e-05 | 702 | 185 | 15 | C0009402 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.11e-05 | 152 | 185 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | ANKK1 ANK3 ABCA13 SYNE1 NTRK2 LARS2 NR1D1 ITPR1 PACS1 TRANK1 ARHGEF10 PIK3C3 | 5.20e-05 | 477 | 185 | 12 | C0005586 |
| Disease | breast ductal carcinoma (is_implicated_in) | 1.17e-04 | 3 | 185 | 2 | DOID:3007 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | CYP3A5 KAT6A BCAR1 ITPR1 JAK1 CHD6 ATM HSD17B3 PCDH8 MED12 GOLGA4 VCP ZNF292 | 1.48e-04 | 616 | 185 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | CYP3A5 KAT6A BCAR1 ITPR1 JAK1 CHD6 ATM HSD17B3 PCDH8 MED12 GOLGA4 VCP ZNF292 | 1.48e-04 | 616 | 185 | 13 | C0376358 |
| Disease | body weight | KNTC1 NRCAM NTRK2 ADGRB3 ARHGEF12 ATP13A5 ZSWIM6 HUWE1 PPFIA3 CWC22 RSU1 CDK10 ITPR1 MAP4K5 ASL MICA KAZN NIPBL MAML3 | 3.84e-04 | 1261 | 185 | 19 | EFO_0004338 |
| Disease | colorectal adenoma (is_implicated_in) | 3.86e-04 | 5 | 185 | 2 | DOID:0050860 (is_implicated_in) | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 3.86e-04 | 5 | 185 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 3.86e-04 | 5 | 185 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 3.86e-04 | 5 | 185 | 2 | C4551851 | |
| Disease | Depressive disorder | 5.04e-04 | 289 | 185 | 8 | C0011581 | |
| Disease | De Lange syndrome | 5.77e-04 | 6 | 185 | 2 | cv:C0270972 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 5.77e-04 | 6 | 185 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | Alcohol Related Birth Defect | 5.77e-04 | 6 | 185 | 2 | C3146244 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 5.77e-04 | 6 | 185 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 5.89e-04 | 163 | 185 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Child Development Disorders, Specific | 7.86e-04 | 29 | 185 | 3 | C0085997 | |
| Disease | Child Development Deviations | 7.86e-04 | 29 | 185 | 3 | C0085996 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 8.04e-04 | 7 | 185 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 8.04e-04 | 7 | 185 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | Developmental Disabilities | 8.69e-04 | 30 | 185 | 3 | C0008073 | |
| Disease | Manic Disorder | 1.05e-03 | 71 | 185 | 4 | C0024713 | |
| Disease | Frontotemporal Dementia With Motor Neuron Disease | 1.07e-03 | 8 | 185 | 2 | C3888102 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.07e-03 | 8 | 185 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Cornelia De Lange Syndrome | 1.07e-03 | 8 | 185 | 2 | C0270972 | |
| Disease | testosterone measurement | SLC22A25 ANK2 ANK3 STAG1 TFAP2E CYP4B1 CWC22 RSU1 C2CD2 PKNOX2 THADA ANAPC1 MAP4K5 CNKSR3 C18orf63 KAZN MED12 SOS2 | 1.15e-03 | 1275 | 185 | 18 | EFO_0004908 |
| Disease | intellectual disability (implicated_via_orthology) | 1.28e-03 | 75 | 185 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | underweight body mass index status | 1.37e-03 | 9 | 185 | 2 | EFO_0005936 | |
| Disease | serine measurement | 1.37e-03 | 35 | 185 | 3 | EFO_0009774 | |
| Disease | Manic | 1.49e-03 | 78 | 185 | 4 | C0338831 | |
| Disease | Depression, Bipolar | 1.56e-03 | 79 | 185 | 4 | C0005587 | |
| Disease | Alcoholic Intoxication, Chronic | 1.57e-03 | 268 | 185 | 7 | C0001973 | |
| Disease | Essential hypertension | 1.70e-03 | 10 | 185 | 2 | cv:C0085580 | |
| Disease | Essential hypertension, genetic | 1.70e-03 | 10 | 185 | 2 | cv:CN305331 | |
| Disease | HYPERTENSION, ESSENTIAL | 1.70e-03 | 10 | 185 | 2 | 145500 | |
| Disease | glycerophosphorylcholine measurement | 2.07e-03 | 11 | 185 | 2 | EFO_0020018 | |
| Disease | Intellectual Disability | 2.14e-03 | 447 | 185 | 9 | C3714756 | |
| Disease | age-related macular degeneration, disease progression measurement | 2.17e-03 | 41 | 185 | 3 | EFO_0001365, EFO_0008336 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.48e-03 | 12 | 185 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | response to carboplatin, methylcobalamin deficiency type cblE, response to antineoplastic agent | 2.48e-03 | 12 | 185 | 2 | GO_0097327, GO_0097328, MONDO_0009354 | |
| Disease | Essential Hypertension | 2.48e-03 | 12 | 185 | 2 | C0085580 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 2.48e-03 | 12 | 185 | 2 | EFO_0800453 | |
| Disease | brain disease (is_implicated_in) | 2.48e-03 | 12 | 185 | 2 | DOID:936 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 2.83e-03 | 93 | 185 | 4 | C1535926 | |
| Disease | alcohol and nicotine codependence | 2.91e-03 | 13 | 185 | 2 | EFO_0004776 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 2.91e-03 | 13 | 185 | 2 | OBA_2045082 | |
| Disease | bipolar disorder | ANK3 SYNE1 ZSWIM6 HUWE1 PTGIS PACS1 TRANK1 KCNU1 XPNPEP3 PUS7 | 3.64e-03 | 577 | 185 | 10 | MONDO_0004985 |
| Disease | Adenoid Cystic Carcinoma | 3.67e-03 | 100 | 185 | 4 | C0010606 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 3.81e-03 | 101 | 185 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Romano-Ward Syndrome | 4.43e-03 | 16 | 185 | 2 | C0035828 | |
| Disease | Intrahepatic cholestasis of pregnancy | 4.43e-03 | 16 | 185 | 2 | EFO_0009048 | |
| Disease | migraine without aura, susceptibility to, 4 | 4.43e-03 | 16 | 185 | 2 | MONDO_0011847 | |
| Disease | smoking cessation | 4.57e-03 | 325 | 185 | 7 | EFO_0004319 | |
| Disease | major depressive disorder (is_implicated_in) | 5.00e-03 | 17 | 185 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 5.00e-03 | 17 | 185 | 2 | OBA_2045063 | |
| Disease | Ischemic stroke, fibrinogen measurement | 5.01e-03 | 55 | 185 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Mental Depression | 5.48e-03 | 254 | 185 | 6 | C0011570 | |
| Disease | essential hypertension (is_implicated_in) | 5.60e-03 | 18 | 185 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | migraine disorder, systolic blood pressure | 5.60e-03 | 18 | 185 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | fibrinogen measurement, factor VII measurement | 5.81e-03 | 58 | 185 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | insulin resistance | 6.09e-03 | 59 | 185 | 3 | EFO_0002614 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 6.23e-03 | 19 | 185 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 6.23e-03 | 19 | 185 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 6.23e-03 | 19 | 185 | 2 | C1275081 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 6.23e-03 | 19 | 185 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Costello syndrome (disorder) | 6.23e-03 | 19 | 185 | 2 | C0587248 | |
| Disease | hydrocephalus (implicated_via_orthology) | 6.23e-03 | 19 | 185 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 6.23e-03 | 19 | 185 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | triglyceride measurement, body mass index | 6.23e-03 | 19 | 185 | 2 | EFO_0004340, EFO_0004530 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLKGALMLENLQKHS | 101 | Q9UKV3 | |
| ALHAQMNGRKITLKR | 3096 | Q99996 | |
| ILLLQDMLKNTSKGH | 571 | O15013 | |
| RVIALAHKTLKMGNL | 656 | Q4VNC0 | |
| KFKAMQSNGILLHRE | 211 | Q9BZ76 | |
| LRRKLKLGTGEMNIH | 816 | Q7Z7A1 | |
| LKSLHGTVMKINQER | 1001 | Q7Z7A1 | |
| QLMEKLREKQLSHSL | 91 | Q9HBH7 | |
| ALHAKLSRQLQKMED | 536 | P56945 | |
| LLRKNHSIMQLCNSK | 101 | O60242 | |
| LNDKQKHRLDFLQLM | 261 | P20815 | |
| ADNMKKIILSHRQAL | 261 | P08910 | |
| KNHVRVMELLLKTGA | 381 | P16157 | |
| LKPGNILLDSNMHVK | 146 | Q8NFD2 | |
| AAMRLAKQKSLTQLH | 496 | A5YM72 | |
| RHLLSEMNKGIKSIN | 2076 | Q86UQ4 | |
| LMLLQDSNKKSHIAL | 4156 | Q86UQ4 | |
| KMKLLPRKSHDNAQL | 291 | O43184 | |
| LRKKSGMQIALNDHL | 301 | P24530 | |
| SKLTNNFEKLRLHQM | 101 | Q05D60 | |
| LQLEIDQLKHSLMKA | 206 | Q9H257 | |
| LHIGLNEQMKAVRKR | 841 | Q9NZN5 | |
| GELHSRKSMLLAAKQ | 336 | Q6VUC0 | |
| QLGAHLEQLKMTIKS | 296 | Q8IYR0 | |
| HMLLNLSRGKQDFLK | 356 | P49792 | |
| VHLALKLNNSELMGR | 341 | P42696 | |
| GMLNDNRKRLLLNLH | 1586 | Q2KHR3 | |
| DLMSHLKKQILRTDN | 521 | P23458 | |
| ARHNKLLQQMLKPGS | 2116 | Q14571 | |
| MPLLQTLDNLKEGKH | 96 | Q17RG1 | |
| IRMLLNQHSLLFGGK | 191 | Q15118 | |
| LRMTLAHIKDQKEGL | 96 | Q29983 | |
| GNLKVLQLCRFLHMK | 1531 | Q9H1A4 | |
| HVASKRGNTNMVKLL | 271 | Q01484 | |
| LQQLLRDSHLKMLAK | 186 | Q96NW4 | |
| KHNKIPRSELLNELM | 601 | Q96EY7 | |
| AKHILMQKQRALSDL | 4116 | Q9NU22 | |
| MQKQRALSDLFKHLA | 4121 | Q9NU22 | |
| IPHLAANLKKMNQAL | 156 | Q9NVX0 | |
| NSLMKRDLEKHLNVS | 556 | Q674X7 | |
| AHLSEDQKRLLLMKQ | 661 | Q96JK9 | |
| GKALEGMFRKLNHLL | 336 | O43292 | |
| MNQKLLKLENLLRFH | 1 | P46199 | |
| LPLDMAALVHAKKAQ | 1116 | Q86VF7 | |
| VARNKLGMAKNEVHL | 526 | Q92823 | |
| RLSNAKKQALHAVMG | 126 | Q16538 | |
| LARHNKELQSMLKPG | 2171 | Q14643 | |
| MLRKNQHLRHLDLSK | 976 | Q86W28 | |
| MHLKLKGNLALSQAF | 446 | Q9HBX8 | |
| LELKHNSTLKQLMRE | 1986 | Q13439 | |
| DILKSRLKEGHMNPQ | 3146 | Q03001 | |
| MALEKKLNQALLDLH | 101 | P02792 | |
| LIKKMGDHLTNLHRL | 141 | P02792 | |
| NKHVGSNMKLLRVDI | 2446 | Q07954 | |
| ARMLDHLNKKELRGQ | 981 | O75145 | |
| KAGLLTKAEMDQILH | 51 | P04424 | |
| LGLLHEQNMAKMRLL | 266 | Q7L2H7 | |
| HNGLQMILEDKRILK | 141 | Q8NHP7 | |
| QELSELVKNRMKHLG | 1121 | Q5JUK3 | |
| TNKLRNVAKMFAHLL | 541 | Q9HCG8 | |
| TGHRLLNMLRKTLKE | 71 | Q53TS8 | |
| LMKCVNHKNIIGLLN | 76 | P45983 | |
| ISGDALKKDLINHMQ | 931 | O95206 | |
| QQMHLVSKLKILRLG | 136 | Q6UY01 | |
| MHQLFRLVLGQKDLS | 1 | Q14D04 | |
| LLMLKQHLKNLCGFS | 2546 | Q6KC79 | |
| LGATHKELMILKEQN | 196 | Q13136 | |
| ARMLDHLTKKDLRGQ | 991 | Q13136 | |
| KLHRQALALQMSKQE | 1051 | P50748 | |
| KQLMHEALKLRLNLV | 1526 | Q93074 | |
| HFLNSMKNKILTQRL | 516 | A8MYU2 | |
| FQELMKLALNQGKIH | 76 | Q9NPJ6 | |
| PHFLKREGNKLQIML | 101 | Q86VP3 | |
| CIIRLIKHDLKMNSG | 411 | P49916 | |
| LQREKAAQMHLVLLK | 176 | Q8WWQ2 | |
| HNGMNNIIRLFLKKG | 2206 | Q7Z6Z7 | |
| MNHQALVRKLPDLEK | 341 | Q9NX62 | |
| KANLHALIQMKPALS | 781 | Q6R327 | |
| ALIQMKPALSHLGDK | 786 | Q6R327 | |
| LGHQKKLMLGVKRLA | 606 | Q8WXE0 | |
| LAALHLMASPKVNKD | 521 | Q86WI3 | |
| HFLKRDANKLQIMLQ | 181 | Q6VY07 | |
| GSLKMNNIELHKQGL | 376 | Q5TIA1 | |
| LKGALHRALQRKRSM | 296 | Q6IF42 | |
| KLIQDHMAKLQLNLR | 751 | Q92794 | |
| KLPDLRTLNNMHSEK | 591 | P20393 | |
| MQSLLLQRKASGLHE | 451 | Q9P2J9 | |
| MLKSENLLGKQIDHL | 1321 | Q13315 | |
| LLQLSKMAINHTGEK | 1651 | Q13315 | |
| NCKLLEGLKLMNLEH | 1006 | Q3L8U1 | |
| MNLRKTHILQKAPAL | 871 | O60308 | |
| GNSVLLHISKLQMKD | 101 | Q93033 | |
| KLLSRHRNKNTMNGA | 676 | Q9Y426 | |
| QANIKNGKHLLMSIS | 1771 | Q8TD26 | |
| HRDLKVSNLLMTDKG | 161 | Q15131 | |
| NALLREQLEHMKKAN | 171 | H7BZ55 | |
| RMHSLLIKNLKNEIT | 431 | P53621 | |
| NVKLAQHALAGMQKL | 61 | Q5TH69 | |
| MARLVLKSKNGIHLR | 491 | Q5TCH4 | |
| RALGITLMGHQKKIL | 971 | P29322 | |
| MSHSREKLLNALEKL | 411 | Q5T764 | |
| MATLLLFKHQKLLGE | 466 | Q6NUI2 | |
| LHVVLKGSNNDMKVL | 441 | Q9NWK9 | |
| NRIKVMELLLKHGAS | 411 | Q12955 | |
| ANLMKTLQHDKLVRL | 291 | P07948 | |
| HIRKLLQKMDRPNGL | 361 | O60476 | |
| DVVTKKRLRNMLGHL | 301 | Q86Y33 | |
| QLLKVLGTRKLMHVA | 391 | Q14204 | |
| HLLLRRQTLAKAMDK | 31 | P13584 | |
| KKMLNKVNLGHAART | 1726 | Q05BV3 | |
| QMRLSGKKHLLQELR | 661 | P57679 | |
| NALMHALTDLRKKNP | 836 | Q14527 | |
| LAKKQLLMVRQAALH | 61 | Q5VU69 | |
| ALHLMQNLDTKSKLR | 766 | Q9Y4K1 | |
| RQAKQIVSSAKMLLH | 1056 | Q8TDG4 | |
| AQMELKKSLHGEARI | 166 | Q9NVL8 | |
| QKMLKNLKEGGHRVL | 1056 | Q14839 | |
| HMPAALQDFLLLKQK | 296 | Q9BPW9 | |
| QLILKHMESRQKGLI | 166 | P37058 | |
| LKELRKAAHRNGMKN | 296 | Q6T423 | |
| TMGNLKQHLLTHRLK | 1016 | Q9BXA9 | |
| LKTKMHSDNLLRNDL | 166 | Q96KN3 | |
| RKNMAPQRKDLHGLS | 1131 | Q9C0B2 | |
| LKTSMIQHDKLNLGP | 471 | Q68DL7 | |
| VGQLMDGLKQLKLHR | 336 | Q13822 | |
| KFKAMQSNGILLHRE | 211 | Q96NU0 | |
| LLARVDHLMKVGKNN | 181 | Q9UNQ2 | |
| KMHRDIKGANILLTD | 136 | Q9Y4K4 | |
| ILLSILKMHSAKGRQ | 251 | Q8NGG3 | |
| QLSMLKKAHGLLAEE | 1436 | Q14980 | |
| LHGLQLKMSILQSRE | 756 | Q9BVI0 | |
| QISSLQKLKHLNLGM | 81 | Q15404 | |
| QKLKHLNLGMNRLNT | 86 | Q15404 | |
| NQHLAMLAKKLELDR | 1006 | Q9NRR4 | |
| ALRHQTKIMFKNLLQ | 406 | Q6YHU6 | |
| LEDTKMNGHLRLLNI | 506 | Q8TEU7 | |
| KNIVHRDLKLGNMVL | 191 | Q8N2I9 | |
| RDLKLGNMVLNKRTH | 196 | Q8N2I9 | |
| DKEINSPNLLKMIRH | 811 | Q07890 | |
| RKLILAGNIIHSLMK | 366 | Q9H5Y7 | |
| LLTSHQNLLRMTKEK | 2601 | Q8NF91 | |
| NKEKLLMISRSHNNL | 456 | Q86VY9 | |
| QSNIKHMRKQLDRLG | 151 | Q15031 | |
| ENHIMSNLRQVGLKK | 831 | Q7Z7B0 | |
| QHTFLKNMGIDVRLK | 356 | Q7L592 | |
| HMLLNLSRGKQDFLK | 356 | P0DJD1 | |
| KARMKLTLLHRELQA | 121 | Q16647 | |
| FQMHRALAALKNKPL | 16 | Q14CZ7 | |
| NARTKFHVLKMLLNL | 731 | Q96D09 | |
| ALHLGSQLLRELKKM | 146 | O00231 | |
| QMSRLAKLTKAHRQG | 171 | Q8NEB9 | |
| MQLALFQGIAKKHRA | 401 | Q96BP3 | |
| LDKALELNMLSLKGH | 321 | Q9Y617 | |
| QRLAHLNKCLMNFKL | 311 | Q96PZ0 | |
| IHKDPEQLMNTLRKL | 576 | P30876 | |
| DNLKKLRMLDLRHNK | 166 | Q9UQ13 | |
| KNLMQLNLAHNILRK | 221 | P51888 | |
| KDDFLHGLQMLKSLQ | 116 | Q9H5K3 | |
| VLGKKQEALRILQMH | 96 | A8MT33 | |
| LVSKMLRAVLQSHKN | 6 | Q8NHU6 | |
| HKGLLELNQMRAFKS | 286 | Q96EM0 | |
| ILHRDMKPQNILLAK | 121 | Q9NRP7 | |
| INRKLSAAGMHEALK | 406 | P34969 | |
| MKNLVLKLRASSHNL | 81 | G9CGD6 | |
| MKNLVLKLRASSHNL | 81 | Q6P9H4 | |
| LGDNLMALNHADKLL | 546 | Q9H9A5 | |
| MALNHADKLLQQPKL | 551 | Q9H9A5 | |
| MRKNIKGIHTLLQNL | 796 | Q16620 | |
| LHMLQRKLGRKLNPE | 216 | Q8NEY3 | |
| LKDLEQLAKMLGHSA | 4621 | Q63HN8 | |
| VLHKDKSLENLGMLR | 251 | Q5T4D3 | |
| LLFKQKSNGMHSLIA | 666 | Q2NL82 | |
| KSLEHLRKQMQDALL | 141 | Q96F44 | |
| DQKLLLAGMHRNLAI | 196 | Q9NXC5 | |
| QLLKLMSTVDPKLNH | 186 | Q05519 | |
| SQLLTLMDGLKQRAH | 326 | P55072 | |
| GRLEILQIHTKNMKL | 376 | P55072 | |
| TGLFELSQHMKLKLQ | 461 | Q8WVR3 | |
| KRIIHRDLKAGNVLM | 151 | O94804 | |
| PSRKIMLNLEGHKQE | 71 | Q6ZV73 | |
| LLDMRIKHLIKTNQL | 191 | O60281 | |
| RHNLLQACKMQDIKL | 926 | Q14683 | |
| TGRMEKHLDALLKQI | 606 | Q8WVM7 | |
| HRLAAKSLLQTKDMG | 546 | O00534 | |
| TGKENKVLLAMNLHN | 191 | Q9UBV4 | |
| NSSPVINHLLLGKKM | 676 | Q9Y2I9 | |
| GKLHTQPKLAAQLRM | 371 | O15195 | |
| PDNMLLDKSGHLKLA | 201 | Q13464 | |
| LHGRRNSGKLMSLDK | 1121 | Q9HCJ5 | |
| RHKLMSLIQKEAQGQ | 76 | Q9NQH7 | |
| KKLMHQAALLGQALC | 211 | Q86VQ6 | |
| ILNGLHEEMLNLKKL | 531 | Q14694 | |
| HEEMLNLKKLLSPSN | 536 | Q14694 | |
| LRKLHGLEILNSTMK | 686 | Q9H892 | |
| LFAQKRTMLEHLKNT | 866 | Q8N1G0 | |
| SLRPHKMKSLLGQNV | 551 | Q96Q05 | |
| LHLLEDLSIKNKQRM | 11 | Q8N8F6 | |
| MTDQVKLALNKHLLG | 2116 | O15050 | |
| RKMLHLRKQLLSLTN | 621 | Q9UHD2 | |
| KLSLKNRILNHFGPM | 686 | Q496Y0 |